Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) vs Adult obesity prevalence (age-standardized, %) in Andorra
In 2024, measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) in Andorra stood at 98%, against 17.1% for adult obesity prevalence (age-standardized, %).
Change the pair
Compare different indicators
The series
Over time
Andorra, spaced by time. Both series are in %, so they share one axis; the legend names each line.
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) and Adult obesity prevalence (age-standardized, %)
Unit: % · 61 observations
Estimates are listed as such in the table below
View the underlying data
| Indicator | Period | Type | Value |
|---|---|---|---|
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2025 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2024 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2023 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2022 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2021 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2020 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2019 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2018 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2017 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2016 | Estimate | 97% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2015 | Estimate | 96% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2014 | Estimate | 96% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2013 | Estimate | 95% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2012 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2011 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2010 | Estimate | 99% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2009 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2008 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2007 | Estimate | 94% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2006 | Estimate | 91% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2005 | Estimate | 94% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2004 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2003 | Estimate | 96% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2002 | Estimate | 98% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2001 | Estimate | 97% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | 2000 | Estimate | 97% |
| Adult obesity prevalence (age-standardized, %) | 2024 | Estimate | 17.1% |
| Adult obesity prevalence (age-standardized, %) | 2023 | Estimate | 17.1% |
| Adult obesity prevalence (age-standardized, %) | 2022 | Estimate | 17.1% |
| Adult obesity prevalence (age-standardized, %) | 2021 | Estimate | 17.1% |
| Adult obesity prevalence (age-standardized, %) | 2020 | Estimate | 17% |
| Adult obesity prevalence (age-standardized, %) | 2019 | Estimate | 17% |
| Adult obesity prevalence (age-standardized, %) | 2018 | Estimate | 17% |
| Adult obesity prevalence (age-standardized, %) | 2017 | Estimate | 17% |
| Adult obesity prevalence (age-standardized, %) | 2016 | Estimate | 17% |
| Adult obesity prevalence (age-standardized, %) | 2015 | Estimate | 17% |
| Adult obesity prevalence (age-standardized, %) | 2014 | Estimate | 16.9% |
| Adult obesity prevalence (age-standardized, %) | 2013 | Estimate | 16.9% |
| Adult obesity prevalence (age-standardized, %) | 2012 | Estimate | 16.8% |
| Adult obesity prevalence (age-standardized, %) | 2011 | Estimate | 16.7% |
| Adult obesity prevalence (age-standardized, %) | 2010 | Estimate | 16.6% |
| Adult obesity prevalence (age-standardized, %) | 2009 | Estimate | 16.4% |
| Adult obesity prevalence (age-standardized, %) | 2008 | Estimate | 16.2% |
| Adult obesity prevalence (age-standardized, %) | 2007 | Estimate | 15.9% |
| Adult obesity prevalence (age-standardized, %) | 2006 | Estimate | 15.6% |
| Adult obesity prevalence (age-standardized, %) | 2005 | Estimate | 15.3% |
| Adult obesity prevalence (age-standardized, %) | 2004 | Estimate | 14.9% |
| Adult obesity prevalence (age-standardized, %) | 2003 | Estimate | 14.6% |
| Adult obesity prevalence (age-standardized, %) | 2002 | Estimate | 14.2% |
| Adult obesity prevalence (age-standardized, %) | 2001 | Estimate | 13.9% |
| Adult obesity prevalence (age-standardized, %) | 2000 | Estimate | 13.5% |
| Adult obesity prevalence (age-standardized, %) | 1999 | Estimate | 13.2% |
| Adult obesity prevalence (age-standardized, %) | 1998 | Estimate | 12.8% |
| Adult obesity prevalence (age-standardized, %) | 1997 | Estimate | 12.5% |
| Adult obesity prevalence (age-standardized, %) | 1996 | Estimate | 12.2% |
| Adult obesity prevalence (age-standardized, %) | 1995 | Estimate | 11.9% |
| Adult obesity prevalence (age-standardized, %) | 1994 | Estimate | 11.7% |
| Adult obesity prevalence (age-standardized, %) | 1993 | Estimate | 11.4% |
| Adult obesity prevalence (age-standardized, %) | 1992 | Estimate | 11.2% |
| Adult obesity prevalence (age-standardized, %) | 1991 | Estimate | 11.1% |
| Adult obesity prevalence (age-standardized, %) | 1990 | Estimate | 10.9% |
Shared periods
Side by side
25 periods are published for both series in Andorra as annual figures on the same basis. Comparing anything else would mean comparing different periods.
| Period | Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | Adult obesity prevalence (age-standardized, %) |
|---|---|---|
| 2000 | 97% WHO | 13.5% WHO |
| 2001 | 97% WHO | 13.9% WHO |
| 2002 | 98% WHO | 14.2% WHO |
| 2003 | 96% WHO | 14.6% WHO |
| 2004 | 98% WHO | 14.9% WHO |
| 2005 | 94% WHO | 15.3% WHO |
| 2006 | 91% WHO | 15.6% WHO |
| 2007 | 94% WHO | 15.9% WHO |
| 2008 | 98% WHO | 16.2% WHO |
| 2009 | 98% WHO | 16.4% WHO |
| 2010 | 99% WHO | 16.6% WHO |
| 2011 | 99% WHO | 16.7% WHO |
| 2012 | 98% WHO | 16.8% WHO |
| 2013 | 95% WHO | 16.9% WHO |
| 2014 | 96% WHO | 16.9% WHO |
| 2015 | 96% WHO | 17% WHO |
| 2016 | 97% WHO | 17% WHO |
| 2017 | 99% WHO | 17% WHO |
| 2018 | 99% WHO | 17% WHO |
| 2019 | 99% WHO | 17% WHO |
| 2020 | 98% WHO | 17% WHO |
| 2021 | 99% WHO | 17.1% WHO |
| 2022 | 98% WHO | 17.1% WHO |
| 2023 | 99% WHO | 17.1% WHO |
| 2024 | 98% WHO | 17.1% WHO |
Provenance
Where these numbers come from
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
The percentage of children under one year of age who have received at least one dose of measles-containing vaccine in a given year (or 12-23 months for countries recommending vaccination after 12 months), based on WHO/UNICEF Estimates of National Immunization Coverage (WUENIC).
26 observations charted in Andorra · source organisations: WHO
Adult obesity prevalence (age-standardized, %)
Percentage of adults aged 18 and older with a body mass index (BMI) of 30 kg/m² or higher, age-standardized estimate.
35 observations charted in Andorra · source organisations: WHO
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring